More Channels, Enhanced Analysis, and Customizable Modular Design
The Guideline 5 is FHC’s next generation neuromodulation targeting system designed for both clinical and research applications. The system efficiently supports functional neurosurgery programs that address movement disorders, epilepsy, pain, and psychiatric disorders. New features allow you to maximize your micro and macro electrode channel count with expanded connection options and improved analytical tools.
The modular system may be purchased in a variety of configurations for your specific neurosurgical procedure needs. Options range from an entry-level base system for new DBS programs to integrated powerful systems for advanced centers of excellence that require additional features such as supplemental auxiliary channels for LFP, ECoG, and SEEG; general purpose digital inputs and outputs; and advanced visualization options.
Shorter Lead Length:
Signal interface placement adjacent to sterile field allows for shorter lead length and improved noise performance, with pole-mounting option suitable for any OR setup
Streamlined User Interface:
For intuitive ease of use
Ergonomically Designed Remote:
Controls application and amplitude of stimulation current along with operation of optional integrated microTargeting™ Drive Power Assist Motor
Expandable to 16, of simultaneous microelectrode and low frequency recording with advanced current steering stimulation capabilities
Software features streamlined, touch-enabled user interface for intuitive use:
- PreOp screen for setting up a new patient and mapping electrode trajectories
- IntraOp screen that provides a wealth of real time display information, control of stimulation and collection of neuron classification, efficacy and side-effect observations
- Summary screen offers full procedure reporting and data export for offline analysis
The system is cleared for use in the United States, the European Union, Australia, and Canada